期刊
ONCOTARGET
卷 7, 期 36, 页码 58351-58366出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.11113
关键词
nasopharyngeal carcinoma; cancer stem cell; CD44; CD24; STAT3
资金
- National Science Council, Taiwan [NSC-96-2320-B-010-035-MY2, NSC-99-2314-B-010-006-MY3, NSC100-2320-B-715-003-MY3, NSC-101-2321-B-010-015-MY3]
- Department of Health, Taipei City [10001-62-030, 099XDAA00121]
- National Yang-Ming University, the Aim for the Top University Plan of the Ministry of Education
Cell surface proteins such as CD44 and CD24 are used to distinguish cancer stem cells (CSCs) from the bulk-tumor population. However, the molecular functionalities of CD24 and CD44, and how these two molecules coordinate in CSCs remain poorly understood. We found that nasopharyngeal carcinoma (NPC) cells with high expression of CD44 and CD24 proteins presented with pronounced CSC properties. Accordingly, a subpopulation of NPC cells with co-expression of CD44 and CD24 were specially enriched in high-stage clinical samples. Furthermore, ectopically expressing the epithelial-mesenchymal transition (EMT) regulator Twist was able to upregulate the stemness factors, and vice versa. This indicates a reciprocal regulation of stemness and EMT. Intriguingly, we found that this reciprocal regulation was differentially orchestrated by CD44 and CD24, and only simultaneous silencing the expression of CD44 and CD24 led to a broad-spectrum suppression of CSC properties. Oppositely, overexpression of CD44 and CD24 induced the reprogramming of parental NPC cells into CSCs through STAT3 activation, which could be blunted by STAT3 inhibition, indicating that CD44 and CD24 collaboratively drive the reprogramming of NPC cells through STAT3-mediated stemness and EMT activation. Consequently, targeting of the CD44/CD24/STAT3 axis may provide a potential therapeutic paradigm for the treatment of NPC through repressing CSC activities.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据